Peer reviewed

Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction.

Babula JAJ, Bui D, Stevenson HL, Watowich SJ, Neelakantan H. Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction. Diabetes Obes Metab. 2024;26(11):5272-5282. doi:10.1111/dom.15879. PMID 39161060.

Diabetes Obes MetabPublished 2024Accessed 2026-07-12

Open original source

Registry record

Source metadata

Publisher: Diabetes Obes Metab
Source type: Peer reviewed
Registry ID: research-amq-02
DOI: 10.1111/dom.15879
PMID: 39161060
Source code: AMQ-02

Source usage

Linked from 1 page

Compound

5-Amino-1MQ

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.